| Primary |
|
|
| Secondary |
| Hiv Infection |
61.9% |
| Drug Use For Unknown Indication |
6.7% |
| Acquired Immunodeficiency Syndrome |
5.1% |
| Antiretroviral Therapy |
4.7% |
| Antifungal Prophylaxis |
2.8% |
| Factor Viii Deficiency |
2.3% |
| Drug Exposure During Pregnancy |
2.1% |
| Maternal Exposure During Pregnancy |
2.1% |
| Insomnia |
1.8% |
| Systemic Antiviral Treatment |
1.4% |
| Hyperuricaemia |
1.3% |
| Product Used For Unknown Indication |
1.2% |
| Bacterial Infection |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Hepatitis C |
0.9% |
| Mycobacterium Avium Complex Infection |
0.9% |
| Weight Decreased |
0.9% |
| Prophylaxis Against Hiv Infection |
0.8% |
| Antibiotic Prophylaxis |
0.7% |
| Diarrhoea |
0.7% |
|
| Lymphoma |
14.3% |
| Parkinsonism |
11.4% |
| Renal Failure Acute |
8.6% |
| Sick Sinus Syndrome |
7.1% |
| Viral Mutation Identified |
5.7% |
| Weight Decreased |
5.7% |
| Drug Exposure During Pregnancy |
4.3% |
| Hyperlipidaemia |
4.3% |
| Pneumocystis Jiroveci Pneumonia |
4.3% |
| Rash |
4.3% |
| Visceral Leishmaniasis |
4.3% |
| Hepatotoxicity |
2.9% |
| Immune Reconstitution Syndrome |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Overdose |
2.9% |
| Portal Vein Thrombosis |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.9% |
| Pyrexia |
2.9% |
| Retinitis |
2.9% |
| Somnolence |
2.9% |
|
| Concomitant |
| Hiv Infection |
35.2% |
| Drug Use For Unknown Indication |
22.1% |
| Acquired Immunodeficiency Syndrome |
14.8% |
| Product Used For Unknown Indication |
8.1% |
| Antiretroviral Therapy |
3.5% |
| Trigeminal Neuralgia |
3.0% |
| End Stage Aids |
2.6% |
| Systemic Antiviral Treatment |
1.8% |
| Antiviral Prophylaxis |
1.7% |
| Hepatitis C |
1.5% |
| Herpes Zoster |
1.1% |
| Prophylaxis |
0.9% |
| Depression |
0.7% |
| Weight Decreased |
0.7% |
| Antibiotic Prophylaxis |
0.4% |
| Cerebrovascular Accident Prophylaxis |
0.4% |
| Diarrhoea |
0.4% |
| Haemophilia |
0.4% |
| Haemorrhage |
0.4% |
| Herpes Simplex |
0.4% |
|
| Visual Disturbance |
16.3% |
| Death |
9.3% |
| Visual Field Defect |
9.3% |
| Walking Disability |
9.3% |
| Liver Function Test Abnormal |
4.7% |
| Mental Status Changes |
4.7% |
| Pathological Fracture |
4.7% |
| Platelet Count Decreased |
4.7% |
| Rhabdomyolysis |
4.7% |
| Transaminases Increased |
4.7% |
| Viral Mutation Identified |
4.7% |
| Vomiting |
4.7% |
| Drug Ineffective |
2.3% |
| Hypoxia |
2.3% |
| Neuropathy Peripheral |
2.3% |
| Panniculitis |
2.3% |
| Paraesthesia |
2.3% |
| Renal Failure |
2.3% |
| Sinusitis |
2.3% |
| Tachypnoea |
2.3% |
|
| Interacting |
| Hiv Infection |
71.4% |
| Liver Transplant |
28.6% |
|
|
